MEHTA, P.; CHANDRAN, V. IL-17 Inhibition vs IL-23 Inhibition for Psoriatic Arthritis: An Ongoing Debate. Canadian Rheumatology Today, Toronto, Canada, v. 2, n. 2, p. 4–14, 2025. DOI: 10.58931/crt.2025.2262. Disponível em: https://canadianrheumatologytoday.com/article/view/2-2-Mehta_et_al. Acesso em: 3 sep. 2025.